Tumor cell-selective apoptosis induction through targeting of KV10.1 via bifunctional TRAIL antibody

Franziska Hartung(Max Planck Institute of Experimental Medicine), Luis A. Pardo(Max Planck Society)
Molecular Cancer
September 7, 2011
10.1186/1476-4598-10-109
Cited by 61

Related Papers

Potassium channels in cell cycle and cell proliferation
|Philosophical Transactions of the Royal Society B Biological Sciences|2014|392
Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment
|Medicinal Research Reviews|2021|40
Cyclic expression of the voltage‐gated potassium channel KV10.1 promotes disassembly of the primary cilium
|EMBO Reports|2016|37